Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Microtubule-Interfering Drugs: Current and Future Roles in Epithelial Ovarian Cancer Treatment
Joan Tymon‐Rosario, Naomi Adjei, Dana M. Roque, et al.
Cancers (2021) Vol. 13, Iss. 24, pp. 6239-6239
Open Access | Times Cited: 20

Showing 20 citing articles:

Noncoding RNAs in the Glycolysis of Ovarian Cancer
Chunmei Zhang, Ning Liu
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Microtubule‐associated proteins and enzymes modifying tubulin
Nannan Peng, Fumihiko Nakamura
Cytoskeleton (2023) Vol. 80, Iss. 3-4, pp. 60-76
Open Access | Times Cited: 10
Paclitaxel in colon cancer management: from conventional chemotherapy to advanced nanocarrier delivery systems
Komal Komal, Bibhu Prasad Nanda, L. Singh, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9449-9474
Closed Access | Times Cited: 3
Trimetazidine alleviates paclitaxel-induced peripheral neuropathy through modulation of TLR4/p38/NF-κB and klotho protein expression
Asmaa Hammad, Mohamed M. Sayed‐Ahmed, Sara Mohamed Naguib Abdel Hafez, et al.
Chemico-Biological Interactions (2023) Vol. 376, pp. 110446-110446
Closed Access | Times Cited: 8
Anticancer Evaluation of Methoxy Poly(Ethylene Glycol)-b-Poly(Caprolactone) Polymeric Micelles Encapsulating Fenbendazole and Rapamycin in Ovarian Cancer
Yu Been Shin, Ju‐Yeon Choi, Dae Hwan Shin, et al.
International Journal of Nanomedicine (2023) Vol. Volume 18, pp. 2209-2223
Open Access | Times Cited: 8
Breaking the Bottleneck in Anticancer Drug Development: Efficient Utilization of Synthetic Biology
Haibo Wang, Yu He, Meiling Jian, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7480-7480
Open Access | Times Cited: 10
Panobinostat Synergistically Enhances the Cytotoxicity of Microtubule Destabilizing Drugs in Ovarian Cancer Cells
María Ovejero-Sánchez, Gloria Asensio-Juárez, Myriam González, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 13019-13019
Open Access | Times Cited: 9
TUBB, a robust biomarker with satisfying abilities in diagnosis, prognosis, and immune regulation via a comprehensive pan-cancer analysis
Zaifu Zhu, Wei Zhang, Shaohu Huo, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 1
Thiazole, a privileged scaffold in drug discovery
Mohammad A. Alam
Elsevier eBooks (2023), pp. 1-19
Closed Access | Times Cited: 3
Microtubule Dynamics and Cancer
Andreas Ritter, Nina‐Naomi Kreis
Cancers (2022) Vol. 14, Iss. 18, pp. 4368-4368
Open Access | Times Cited: 5
Chemotherapy
Surya K. De
Elsevier eBooks (2023), pp. 7-159
Closed Access | Times Cited: 2
Mechanical properties of CTCs in patients with diagnosed ovarian cancer
Chuanzhi Liu, Yuxi Huang, Chunru Zhao, et al.
Journal of Biomechanics (2023) Vol. 160, pp. 111831-111831
Closed Access | Times Cited: 2
Pharmacogenomics and oncology: A therapeutic approach for cancer treatment
Neetu Saini, Monika Kadian, Anil Kumar
Elsevier eBooks (2024), pp. 223-243
Closed Access
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs
Xin Li, Huiqiang Liu, Fanchen Wang, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 26, pp. 4213-4231
Open Access
Microtubule-Targeting Agents: Disruption of the Cellular Cytoskeleton as a Backbone of Ovarian Cancer Therapy
Michael M. Danziger, Helen Noble, Dana M. Roque, et al.
Advances in experimental medicine and biology (2024), pp. 1-19
Closed Access
The Impact of Centrosome Pathologies on Ovarian Cancer Development and Progression with a Focus on Centrosomes as Therapeutic Target
Heide Schatten
Advances in experimental medicine and biology (2024), pp. 37-64
Closed Access
Asparagus officinalis combined with paclitaxel exhibited synergistic anti-tumor activity in paclitaxel-sensitive and -resistant ovarian cancer cells
Xin Zhang, Jiandong Wang, Yali Fan, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 7, pp. 3871-3883
Open Access | Times Cited: 3
Development of hydrazide hydrazone-tethered combretastatin-oxindole derivatives as antimitotic agents
Darshana Bora, Anamika Sharma, Stephy Elza John, et al.
Journal of Molecular Structure (2022) Vol. 1275, pp. 134675-134675
Closed Access | Times Cited: 3
Unveiling microtubule dynamics in lung cancer: Recent findings and prospects for drug delivery and treatment
Megumi Nishitani Yukuyama, Aline de Souza, Mirla Anali Bazán Henostroza, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 89, pp. 105017-105017
Closed Access | Times Cited: 1
Identification of novel aza-analogs of TN-16 as disrupters of microtubule dynamics through a multicomponent reaction
Arash Foroutan, Marco Corazzari, Ambra A. Grolla, et al.
European Journal of Medicinal Chemistry (2022) Vol. 245, pp. 114895-114895
Closed Access | Times Cited: 1
Page 1

Scroll to top